BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singal AK, Kamath PS, Gores GJ, Shah VH. Alcoholic hepatitis: current challenges and future directions. Clin Gastroenterol Hepatol 2014;12:555-64; quiz e31-2. [PMID: 23811249 DOI: 10.1016/j.cgh.2013.06.013] [Cited by in Crossref: 103] [Cited by in F6Publishing: 114] [Article Influence: 11.4] [Reference Citation Analysis]
Number Citing Articles
1 Xu HY, Jiao YH, Li SY, Zhu X, Wang S, Zhang YY, Wei YJ, Shen YJ, Wang W, Shen YX, Shao JT. Hepatocyte-derived MANF mitigates ethanol-induced liver steatosis in mice via enhancing ASS1 activity and activating AMPK pathway. Acta Pharmacol Sin 2023;44:157-68. [PMID: 35655095 DOI: 10.1038/s41401-022-00920-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wakil A, Niazi M, Meybodi MA, Pyrsopoulos NT. Emerging Pharmacotherapies in Alcohol-Associated Hepatitis. J Clin Exp Hepatol 2023;13:116-26. [PMID: 36647403 DOI: 10.1016/j.jceh.2022.06.012] [Reference Citation Analysis]
3 Thakral N, Deutsch-Link S, Singal AK. Therapeutic Pipeline in Alcohol-Associated Liver Disease. Semin Liver Dis 2022. [PMID: 36572032 DOI: 10.1055/s-0042-1759614] [Reference Citation Analysis]
4 Healey M, Sterling RK. Outnumbered: Control Prothrombin Time in Maddrey's Discriminant Function Impacts Steroid Use but Not Mortality in Alcoholic Hepatitis. Biology (Basel) 2022;11. [PMID: 36552342 DOI: 10.3390/biology11121833] [Reference Citation Analysis]
5 Han H, Jin W, Li X. Mesenchymal stem cells-based therapy in liver diseases. Mol Biomed 2022;3:23. [DOI: 10.1186/s43556-022-00088-x] [Reference Citation Analysis]
6 Wakil A, Mohamed M, Tafesh Z, Niazi M, Olivo R, Xia W, Greenberg P, Pyrsopoulos N. Trends in hospitalization for alcoholic hepatitis from 2011 to 2017: A USA nationwide study. World J Gastroenterol 2022; 28(34): 5036-5046 [DOI: 10.3748/wjg.v28.i34.5036] [Reference Citation Analysis]
7 Cho Y, Joshi R, Lowe P, Copeland C, Ribeiro M, Morel C, Catalano D, Szabo G. Granulocyte colony-stimulating factor attenuates liver damage by M2 macrophage polarization and hepatocyte proliferation in alcoholic hepatitis in mice. Hepatol Commun 2022. [PMID: 35997009 DOI: 10.1002/hep4.1925] [Reference Citation Analysis]
8 Vannier AGL, Przybyszewski EM, Shay J, Patel SJ, Schaefer E, Goodman RP, Luther J. Psychotherapy for Alcohol Use Disorder Is Associated With Reduced Risk of Incident Alcohol-Associated Liver Disease. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00765-0. [PMID: 35964893 DOI: 10.1016/j.cgh.2022.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Luther J, Vannier AG, Schaefer EA, Goodman RP. The circulating proteomic signature of alcohol-associated liver disease. JCI Insight 2022;7:e159775. [PMID: 35866482 DOI: 10.1172/jci.insight.159775] [Reference Citation Analysis]
10 Yen Y, Park J, Kang S, Su T, Cheng H, Wen W, Lin S, Tai Y, Chen P, Tsai S. Clinical Benefits of Golden-Antrodia Camphorata Containing Antroquinonol in Liver Protection and Liver Fat Reduction After Alcoholic Hepatitis. Front Pharmacol 2022;13:757494. [DOI: 10.3389/fphar.2022.757494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ayares G, Idalsoaga F, Díaz LA, Arnold J, Arab JP. Current Medical Treatment for Alcohol-Associated Liver Disease. J Clin Exp Hepatol 2022;12:1333-48. [PMID: 36157148 DOI: 10.1016/j.jceh.2022.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Luo J, Zhang J, Lai W, Wang S, Zhou L, Shi Y, Ba J, Hu J, Wang Y, Li L, Wu B. Disseminated Human Parvovirus B19 Infection Induced Multiple Organ Dysfunction Syndrome in an Adult Patient With Alcoholic Hepatitis Complicated by Hemolytic Anemia: A Case Report and Literature Review. Front Immunol 2021;12. [DOI: 10.3389/fimmu.2021.742990] [Reference Citation Analysis]
13 Kang H, Kim MB, Park YK, Lee JY. A mouse model of the regression of alcoholic hepatitis: Monitoring the regression of hepatic steatosis, inflammation, oxidative stress, and NAD+ metabolism upon alcohol withdrawal. J Nutr Biochem 2022;99:108852. [PMID: 34525389 DOI: 10.1016/j.jnutbio.2021.108852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Kim DH, Sim Y, Hwang JH, Kwun IS, Lim JH, Kim J, Kim JI, Baek MC, Akbar M, Seo W, Kim DK, Song BJ, Cho YE. Ellagic Acid Prevents Binge Alcohol-Induced Leaky Gut and Liver Injury through Inhibiting Gut Dysbiosis and Oxidative Stress. Antioxidants (Basel) 2021;10:1386. [PMID: 34573017 DOI: 10.3390/antiox10091386] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
15 Wang R, Mu J. Arbutin attenuates ethanol-induced acute hepatic injury by the modulation of oxidative stress and Nrf-2/HO-1 signaling pathway. J Biochem Mol Toxicol 2021;:e22872. [PMID: 34346143 DOI: 10.1002/jbt.22872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
16 Thanda Han MA, Pyrsopoulos N. Emerging Therapies for Alcoholic Hepatitis. Clin Liver Dis 2021;25:603-24. [PMID: 34229843 DOI: 10.1016/j.cld.2021.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Bhatti S, Kim D, Ahmed A, Cholankeril G. Current Trends in Liver Transplantation for Alcoholic Hepatitis. Clin Liver Dis 2021;25:625-34. [PMID: 34229844 DOI: 10.1016/j.cld.2021.04.002] [Reference Citation Analysis]
18 Cabré N, Duan Y, Llorente C, Conrad M, Stern P, Yamashita D, Schnabl B. Colesevelam Reduces Ethanol-Induced Liver Steatosis in Humanized Gnotobiotic Mice. Cells 2021;10:1496. [PMID: 34198609 DOI: 10.3390/cells10061496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wu T, Shah V. Biomarkers of endothelial dysfunction in alcoholic hepatitis. Hepatol Int 2021;15:855-7. [PMID: 34043159 DOI: 10.1007/s12072-021-10202-w] [Reference Citation Analysis]
20 Chang B, Huang A, Saxena R, Sun Y, Liu S, Zhou G, Li B, Teng G, Zhao J, Zhang W, Jiang Y, Han S, Yang Z, Zhao J, Zou Z, Liangpunsakul S. Hepatic Histopathology Among Excessive Drinkers Without Advanced Liver Disease. Alcohol Alcohol 2021:agab017. [PMID: 33765150 DOI: 10.1093/alcalc/agab017] [Reference Citation Analysis]
21 Ballway JW, Song BJ. Translational Approaches with Antioxidant Phytochemicals against Alcohol-Mediated Oxidative Stress, Gut Dysbiosis, Intestinal Barrier Dysfunction, and Fatty Liver Disease. Antioxidants (Basel) 2021;10:384. [PMID: 33806556 DOI: 10.3390/antiox10030384] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
22 Kedarisetty CK, Kumar A, Sarin SK. Insights into the Role of Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis. Semin Liver Dis 2021;41:67-78. [PMID: 33764486 DOI: 10.1055/s-0040-1719177] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Baig M, Walayat S, Dhillon S, Puli S. Efficacy of Granulocyte Colony Stimulating Factor in Severe Alcoholic Hepatitis: A Systematic Review and Meta-Analysis. Cureus 2020. [DOI: 10.7759/cureus.10474] [Reference Citation Analysis]
24 Xiang X, Hwang S, Feng D, Shah VH, Gao B. Interleukin-22 in alcoholic hepatitis and beyond. Hepatol Int 2020;14:667-76. [PMID: 32892258 DOI: 10.1007/s12072-020-10082-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
25 Arab JP, Sehrawat TS, Simonetto DA, Verma VK, Feng D, Tang T, Dreyer K, Yan X, Daley WL, Sanyal A, Chalasani N, Radaeva S, Yang L, Vargas H, Ibacache M, Gao B, Gores GJ, Malhi H, Kamath PS, Shah VH. An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis. Hepatology 2020;72:441-53. [PMID: 31774566 DOI: 10.1002/hep.31046] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 17.7] [Reference Citation Analysis]
26 Du B, Tan XH, Cheng L, Wang F, Zhang HF. MiR-451a ameliorates alcoholic hepatitis via repressing HDAC8-mediated proinflammatory response. Kaohsiung J Med Sci 2020;36:904-10. [PMID: 32643864 DOI: 10.1002/kjm2.12272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Bertha M, Maddur H. Highlights From the AASLD/EASL ALD Endpoints Conference 2019. Clin Liver Dis (Hoboken) 2020;15:215-8. [PMID: 32617152 DOI: 10.1002/cld.927] [Reference Citation Analysis]
28 Xiong J, Ni J, Chen C, Wang K. miR‑148a‑3p regulates alcoholic liver fibrosis through targeting ERBB3. Int J Mol Med 2020;46:1003-12. [PMID: 32582976 DOI: 10.3892/ijmm.2020.4655] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
29 Ji X, Li L, Lu P, Li X, Tian D, Liu M. NLRP6 exerts a protective role via NF-kB with involvement of CCL20 in a mouse model of alcoholic hepatitis. Biochem Biophys Res Commun 2020;528:485-92. [PMID: 32507279 DOI: 10.1016/j.bbrc.2020.05.171] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
30 Patel R, Poddar P, Choksi D, Pandey V, Ingle M, Khairnar H, Sawant P. Predictors of 1-month and 3-months Hospital Readmissions in Decompensated Cirrhosis: A Prospective Study in a Large Asian Cohort. Ann Hepatol 2019;18:30-9. [PMID: 31113606 DOI: 10.5604/01.3001.0012.7859] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
31 Björnsson ES, Hauksson K, Sigurdardottir R, Arnardottir M, Agustsson AS, Lund SH, Kalaitzakis E. Abstinence from alcohol and alcohol rehabilitation therapy in alcoholic liver disease: a population-based study. Scand J Gastroenterol 2020;55:472-8. [PMID: 32233877 DOI: 10.1080/00365521.2020.1743751] [Reference Citation Analysis]
32 Adejumo AC, Cholankeril G, Iqbal U, Yoo ER, Boursiquot BC, Concepcion WC, Kim D, Ahmed A. Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study. Dig Dis Sci 2020;65:990-1002. [PMID: 31372912 DOI: 10.1007/s10620-019-05759-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
33 Rachakonda V, Bataller R, Duarte-Rojo A. Recent advances in alcoholic hepatitis. F1000Res 2020;9:F1000 Faculty Rev-97. [PMID: 32089834 DOI: 10.12688/f1000research.20394.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
34 Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology 2020;71:306-33. [PMID: 31314133 DOI: 10.1002/hep.30866] [Cited by in Crossref: 262] [Cited by in F6Publishing: 209] [Article Influence: 87.3] [Reference Citation Analysis]
35 Yao J, Cheng Y, Zhang D, Fan J, Zhao Z, Li Y, Jiang Y, Guo Y. Identification of key genes, MicroRNAs and potentially regulated pathways in alcoholic hepatitis by integrative analysis. Gene 2019;720:144035. [DOI: 10.1016/j.gene.2019.144035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
36 Singal AK, Kamath PS. Acute on chronic liver failure in non-alcoholic fatty liver and alcohol associated liver disease. Transl Gastroenterol Hepatol 2019;4:74. [PMID: 31728431 DOI: 10.21037/tgh.2019.09.11] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
37 Wong VW, Singal AK. Emerging medical therapies for non-alcoholic fatty liver disease and for alcoholic hepatitis. Transl Gastroenterol Hepatol. 2019;4:53. [PMID: 31463412 DOI: 10.21037/tgh.2019.06.06] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
38 Suzuki Y, Kakisaka K, Suzuki A, Takahara T, Sasaki T, Sato T, Yonezawa T, Nitta H, Takikawa Y. A Lille model for predicting the response of severe alcoholic hepatitis to corticosteroid treatment in Japanese patients. Hepatol Res 2019;49:758-64. [PMID: 30901152 DOI: 10.1111/hepr.13334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Qian WH, Liu YY, Li X, Pan Y. MicroRNA-141 ameliorates alcoholic hepatitis‑induced intestinal injury and intestinal endotoxemia partially via a TLR4-dependent mechanism. Int J Mol Med 2019;44:569-81. [PMID: 31173169 DOI: 10.3892/ijmm.2019.4221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Shipley LC, Kodali S, Singal AK. Recent updates on alcoholic hepatitis. Dig Liver Dis 2019;51:761-8. [PMID: 31010745 DOI: 10.1016/j.dld.2019.03.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
41 Lee JY, Cho Y, Hong MH, Kim J, Lee DH, Jung YJ, Kim BG, Lee KL, Kim W. Incidence, inhospital mortality, and readmission among patients with alcoholic hepatitis in Korea: A nationwide study. J Gastroenterol Hepatol 2019;34:747-54. [PMID: 30345539 DOI: 10.1111/jgh.14513] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
42 Im GY. Acute Alcoholic Hepatitis. Clin Liver Dis 2019;23:81-98. [PMID: 30454835 DOI: 10.1016/j.cld.2018.09.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
43 Axley PD, Richardson CT, Singal AK. Epidemiology of Alcohol Consumption and Societal Burden of Alcoholism and Alcoholic Liver Disease. Clin Liver Dis 2019;23:39-50. [PMID: 30454831 DOI: 10.1016/j.cld.2018.09.011] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 19.8] [Reference Citation Analysis]
44 Singal AK, Shah VH. Current trials and novel therapeutic targets for alcoholic hepatitis. J Hepatol 2019;70:305-13. [PMID: 30658731 DOI: 10.1016/j.jhep.2018.10.026] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 13.5] [Reference Citation Analysis]
45 Lee YJ, Shu MS, Kim JY, Kim YH, Sim KH, Sung WJ, Eun JR. Cilostazol protects hepatocytes against alcohol-induced apoptosis via activation of AMPK pathway. PLoS One 2019;14:e0211415. [PMID: 30695051 DOI: 10.1371/journal.pone.0211415] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
46 Tasdogan BE, Akosman S, Gurakar M, Simsek C, Gurakar A. Update on Liver Transplantation: What is New Recently? Euroasian J Hepatogastroenterol 2019;9:34-9. [PMID: 31988865 DOI: 10.5005/jp-journals-10018-1293] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
47 Kumar M, Gupta GK, Wanjari SJ, Tak V, Ameta M, Nijhawan S. Relative Adrenal Insufficiency in Patients with Alcoholic Hepatitis. J Clin Exp Hepatol 2019;9:215-20. [PMID: 31024204 DOI: 10.1016/j.jceh.2018.09.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
48 Sujan R, Cruz-Lemini M, Altamirano J, Simonetto DA, Maiwall R, Axley P, Richardson T, Desai V, Cabezas J, Vargas V, Kamath PS, Shah VH, Sarin SK, Bataller R, Singal AK. A Validated Score Predicts Acute Kidney Injury and Survival in Patients With Alcoholic Hepatitis. Liver Transpl 2018;24:1655-64. [PMID: 30153377 DOI: 10.1002/lt.25328] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
49 Obed A, Bashir A, Stern S, Jarrad A. Severe acute alcoholic hepatitis and liver transplant: A never-ending mournful story. Clin Mol Hepatol 2018;24:358-66. [PMID: 30360030 DOI: 10.3350/cmh.2018.0044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
50 Al-Saeedi M, Barout MH, Probst P, Khajeh E, Weiss KH, Diener MK, Mehrabi A. Meta-analysis of patient survival and rate of alcohol relapse in liver-transplanted patients for acute alcoholic hepatitis. Langenbecks Arch Surg 2018;403:825-36. [PMID: 30349998 DOI: 10.1007/s00423-018-1720-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
51 Brown ZJ, Heinrich B, Greten TF. Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research. Nat Rev Gastroenterol Hepatol 2018;15:536-54. [PMID: 29904153 DOI: 10.1038/s41575-018-0033-6] [Cited by in Crossref: 100] [Cited by in F6Publishing: 102] [Article Influence: 20.0] [Reference Citation Analysis]
52 Peeraphatdit TB, Simonetto DA, Shah VH. Exploring new treatment paradigms for alcoholic hepatitis by extrapolating from NASH and cholestasis. J Hepatol 2018;69:275-7. [PMID: 29792896 DOI: 10.1016/j.jhep.2018.05.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
53 Singal AK, Louvet A, Shah VH, Kamath PS. Grand Rounds: Alcoholic Hepatitis. J Hepatol 2018;69:534-43. [PMID: 29753761 DOI: 10.1016/j.jhep.2018.05.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
54 Das S, Maras JS, Maiwall R, Shasthry SM, Hussain S, Sharma S, Sukriti S, Singh TP, Sarin SK. Molecular Ellipticity of Circulating Albumin-Bilirubin Complex Associates With Mortality in Patients With Severe Alcoholic Hepatitis. Clin Gastroenterol Hepatol 2018;16:1322-1332.e4. [PMID: 29155355 DOI: 10.1016/j.cgh.2017.11.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
55 Marroni CA, Fleck Jr AM, Fernandes SA, Galant LH, Mucenic M, de Mattos Meine MH, Mariante-Neto G, Brandão ABM. Liver transplantation and alcoholic liver disease: History, controversies, and considerations. World J Gastroenterol 2018; 24(26): 2785-2805 [PMID: 30018475 DOI: 10.3748/wjg.v24.i26.2785] [Cited by in CrossRef: 68] [Cited by in F6Publishing: 69] [Article Influence: 13.6] [Reference Citation Analysis]
56 Ma M, Falloon K, Chen PH, Saberi B, Pustavoitau A, Ozdogan E, Li Z, Philosophe B, Cameron AM, Gurakar A. The Role of Liver Transplantation in Alcoholic Hepatitis. J Intensive Care Med 2019;34:277-91. [PMID: 29879862 DOI: 10.1177/0885066618780339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
57 Xie J, Tian XF, He SG, Wei YL, Peng B, Wu ZQ. Evaluating the Intoxicating Degree of Liquor Products with Combinations of Fusel Alcohols, Acids, and Esters. Molecules 2018;23:E1239. [PMID: 29789494 DOI: 10.3390/molecules23061239] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
58 Rahman MA, Gong Y, Kumar S. In vitro evaluation of structural analogs of diallyl sulfide as novel CYP2E1 inhibitors for their protective effect against xenobiotic-induced toxicity and HIV replication. Toxicol Lett 2018;292:31-8. [PMID: 29694836 DOI: 10.1016/j.toxlet.2018.04.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
59 Nahas J, Im GY. Early liver transplantation for severe alcoholic hepatitis. Clin Liver Dis (Hoboken) 2018;11:69-72. [PMID: 30992792 DOI: 10.1002/cld.693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
60 Sukriti S, Maras JS, Bihari C, Das S, Vyas AK, Sharma S, Hussain S, Shasthry S, Choudhary A, Premkumar M, Kumar D, Kumar G, Mukhopadhyay C, Kumar A, Trehanpati N, Rautou PE, Moreau R, Sarin SK. Microvesicles in hepatic and peripheral vein can predict nonresponse to corticosteroid therapy in severe alcoholic hepatitis. Aliment Pharmacol Ther 2018;47:1151-61. [PMID: 29460445 DOI: 10.1111/apt.14564] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
61 Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol 2018;113:175-94. [PMID: 29336434 DOI: 10.1038/ajg.2017.469] [Cited by in Crossref: 344] [Cited by in F6Publishing: 332] [Article Influence: 68.8] [Reference Citation Analysis]
62 Liangpunsakul S, Crabb DW. Natural History and Cofactors of Alcoholic Liver Disease. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00023-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
63 Gao B, Zakhari S. Epidemiology and Pathogenesis of Alcoholic Liver Disease. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00022-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
64 Singal AK, Shah VH. Prevention and Management of Alcoholic Liver Disease. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00024-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
65 Choi Y, Abdelmegeed MA, Song BJ. Preventive effects of indole-3-carbinol against alcohol-induced liver injury in mice via antioxidant, anti-inflammatory, and anti-apoptotic mechanisms: Role of gut-liver-adipose tissue axis. J Nutr Biochem 2018;55:12-25. [PMID: 29331880 DOI: 10.1016/j.jnutbio.2017.11.011] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 7.2] [Reference Citation Analysis]
66 Skalny AV, Skalnaya MG, Grabeklis AR, Skalnaya AA, Tinkov AA. Zinc deficiency as a mediator of toxic effects of alcohol abuse. Eur J Nutr 2018;57:2313-22. [PMID: 29177978 DOI: 10.1007/s00394-017-1584-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
67 Cho YE, Mezey E, Hardwick JP, Salem N Jr, Clemens DL, Song BJ. Increased ethanol-inducible cytochrome P450-2E1 and cytochrome P450 isoforms in exosomes of alcohol-exposed rodents and patients with alcoholism through oxidative and endoplasmic reticulum stress. Hepatol Commun 2017;1:675-90. [PMID: 29404485 DOI: 10.1002/hep4.1066] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 7.8] [Reference Citation Analysis]
68 Fung P, Pyrsopoulos N. Emerging concepts in alcoholic hepatitis. World J Hepatol 2017; 9(12): 567-585 [PMID: 28515843 DOI: 10.4254/wjh.v9.i12.567] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
69 Lourens S, Sunjaya DB, Singal A, Liangpunsakul S, Puri P, Sanyal A, Ren X, Gores GJ, Radaeva S, Chalasani N, Crabb DW, Katz B, Kamath PS, Shah VH; TREAT Consortium. Acute Alcoholic Hepatitis: Natural History and Predictors of Mortality Using a Multicenter Prospective Study. Mayo Clin Proc Innov Qual Outcomes 2017;1:37-48. [PMID: 30225400 DOI: 10.1016/j.mayocpiqo.2017.04.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
70 Singal AK, Shah VH, Kamath PS. Infection in Severe Alcoholic Hepatitis: Yet Another Piece in the Puzzle. Gastroenterology 2017;152:938-40. [PMID: 28259797 DOI: 10.1053/j.gastro.2017.02.030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
71 Cho YE, Im EJ, Moon PG, Mezey E, Song BJ, Baek MC. Increased liver-specific proteins in circulating extracellular vesicles as potential biomarkers for drug- and alcohol-induced liver injury. PLoS One 2017;12:e0172463. [PMID: 28225807 DOI: 10.1371/journal.pone.0172463] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
72 Wang S, Ni HM, Dorko K, Kumer SC, Schmitt TM, Nawabi A, Komatsu M, Huang H, Ding WX. Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcohol-induced steatosis and liver injury. Oncotarget 2016;7:17681-98. [PMID: 26769846 DOI: 10.18632/oncotarget.6893] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 9.7] [Reference Citation Analysis]
73 Das S, Maras JS, Hussain MS, Sharma S, David P, Sukriti S, Shasthry SM, Maiwall R, Trehanpati N, Singh TP, Sarin SK. Hyperoxidized albumin modulates neutrophils to induce oxidative stress and inflammation in severe alcoholic hepatitis. Hepatology 2017;65:631-46. [PMID: 27775820 DOI: 10.1002/hep.28897] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 9.2] [Reference Citation Analysis]
74 Xia F, Zeng L, Yao X, Zhou B. Hepatic Apoptosis and Necrosis. Liver Pathophysiology 2017. [DOI: 10.1016/b978-0-12-804274-8.00003-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
75 Liangpunsakul S, Puri P, Shah VH, Kamath P, Sanyal A, Urban T, Ren X, Katz B, Radaeva S, Chalasani N, Crabb DW; Translational Research and Evolving Alcoholic Hepatitis Treatment Consortium. Effects of Age, Sex, Body Weight, and Quantity of Alcohol Consumption on Occurrence and Severity of Alcoholic Hepatitis. Clin Gastroenterol Hepatol 2016;14:1831-1838.e3. [PMID: 27320325 DOI: 10.1016/j.cgh.2016.05.041] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.7] [Reference Citation Analysis]
76 Singal AK, Kamath PS. Live donor liver transplantation for alcoholic hepatitis. Hepatol Int 2017;11:34-7. [PMID: 27714680 DOI: 10.1007/s12072-016-9770-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
77 Ni HM, McGill MR, Chao X, Woolbright BL, Jaeschke H, Ding WX. Caspase Inhibition Prevents Tumor Necrosis Factor-α-Induced Apoptosis and Promotes Necrotic Cell Death in Mouse Hepatocytes in Vivo and in Vitro. Am J Pathol 2016;186:2623-36. [PMID: 27616656 DOI: 10.1016/j.ajpath.2016.06.009] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
78 Blaya D, Coll M, Rodrigo-Torres D, Vila-Casadesús M, Altamirano J, Llopis M, Graupera I, Perea L, Aguilar-Bravo B, Díaz A, Banales JM, Clària J, Lozano JJ, Bataller R, Caballería J, Ginès P, Sancho-Bru P. Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation. Gut 2016;65:1535-45. [PMID: 27196584 DOI: 10.1136/gutjnl-2015-311314] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 10.1] [Reference Citation Analysis]
79 Hilscher M, Shah V. Alcoholic Liver Disease. Practical Gastroenterology and Hepatology Board Review Toolkit 2016. [DOI: 10.1002/9781119127437.ch79] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
80 Gallegos-Orozco JF, Charlton MR. Alcoholic Liver Disease and Liver Transplantation. Clin Liver Dis 2016;20:521-34. [PMID: 27373614 DOI: 10.1016/j.cld.2016.02.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
81 Gholam PM. Prognosis and Prognostic Scoring Models for Alcoholic Liver Disease and Acute Alcoholic Hepatitis. Clin Liver Dis 2016;20:491-7. [PMID: 27373611 DOI: 10.1016/j.cld.2016.02.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
82 Saberi B, Dadabhai AS, Jang YY, Gurakar A, Mezey E. Current Management of Alcoholic Hepatitis and Future Therapies. J Clin Transl Hepatol 2016;4:113-22. [PMID: 27350941 DOI: 10.14218/JCTH.2016.00006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
83 Singal AK, Kodali S, Vucovich LA, Darley-Usmar V, Schiano TD. Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review. Alcohol Clin Exp Res. 2016;40:1390-1402. [PMID: 27254289 DOI: 10.1111/acer.13108] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
84 Greuter T, Shah VH. Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights. J Gastroenterol 2016;51:511-9. [PMID: 26939970 DOI: 10.1007/s00535-016-1190-4] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 12.9] [Reference Citation Analysis]
85 Younossi Z, Henry L. Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality. Gastroenterology 2016;150:1778-85. [PMID: 26980624 DOI: 10.1053/j.gastro.2016.03.005] [Cited by in Crossref: 196] [Cited by in F6Publishing: 196] [Article Influence: 28.0] [Reference Citation Analysis]
86 Sanyal AJ, Miller V. Regulatory Science and Drug Approval for Alcoholic and Nonalcoholic Steatohepatitis. Gastroenterology 2016;150:1723-7. [PMID: 26924092 DOI: 10.1053/j.gastro.2016.02.044] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
87 Hmoud BS, Patel K, Bataller R, Singal AK. Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials. Liver Int 2016;36:721-8. [PMID: 26279269 DOI: 10.1111/liv.12939] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 6.6] [Reference Citation Analysis]
88 Kim SH, Kim BG, Kim W, Oh S, Kim HY, Jung YJ, Jeong JB, Kim JW, Lee KL. Characterization of gastrointestinal hemorrhage and prediction of mortality in Asian patients with alcoholic hepatitis. J Gastroenterol Hepatol 2016;31:814-21. [PMID: 26513408 DOI: 10.1111/jgh.13220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
89 Verma VK, Li H, Wang R, Hirsova P, Mushref M, Liu Y, Cao S, Contreras PC, Malhi H, Kamath PS, Gores GJ, Shah VH. Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles. J Hepatol 2016;64:651-60. [PMID: 26632633 DOI: 10.1016/j.jhep.2015.11.020] [Cited by in Crossref: 145] [Cited by in F6Publishing: 137] [Article Influence: 20.7] [Reference Citation Analysis]
90 Bukong TN, Saha B, Szabo G. HCV, Alcohol, and the Liver. Hepatitis C Virus II 2016. [DOI: 10.1007/978-4-431-56101-9_5] [Reference Citation Analysis]
91 Hasanin M, Dubay DA, McGuire BM, Schiano T, Singal AK. Liver transplantation for alcoholic hepatitis: A survey of liver transplant centers. Liver Transpl 2015;21:1449-52. [PMID: 26136401 DOI: 10.1002/lt.24208] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 5.5] [Reference Citation Analysis]
92 Xu MJ, Cai Y, Wang H, Altamirano J, Chang B, Bertola A, Odena G, Lu J, Tanaka N, Matsusue K, Matsubara T, Mukhopadhyay P, Kimura S, Pacher P, Gonzalez FJ, Bataller R, Gao B. Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans. Gastroenterology 2015;149:1030-41.e6. [PMID: 26099526 DOI: 10.1053/j.gastro.2015.06.009] [Cited by in Crossref: 94] [Cited by in F6Publishing: 93] [Article Influence: 11.8] [Reference Citation Analysis]
93 Shah VH. Managing alcoholic liver disease. Clin Mol Hepatol 2015;21:212-9. [PMID: 26523266 DOI: 10.3350/cmh.2015.21.3.212] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
94 Chirapongsathorn S, Kamath PS, Shah V. Alcoholic hepatitis: Can we outwit the Grim Reaper? Hepatology 2015;62:671-3. [PMID: 25891016 DOI: 10.1002/hep.27852] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
95 Gao B, Shah VH. Combination therapy: New hope for alcoholic hepatitis? Clin Res Hepatol Gastroenterol 2015;39 Suppl 1:S7-S11. [PMID: 26193867 DOI: 10.1016/j.clinre.2015.05.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
96 Rudler M, Mouri S, Charlotte F, Cluzel P, Ngo Y, Munteanu M, Lebray P, Ratziu V, Thabut D, Poynard T. Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis. PLoS One 2015;10:e0134302. [PMID: 26252713 DOI: 10.1371/journal.pone.0134302] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
97 Kamath PS, Therneau T, Shah VH. MELDing the Lille Score to More Accurately Predict Mortality in Alcoholic Hepatitis. Gastroenterology 2015;149:281-3. [PMID: 26116805 DOI: 10.1053/j.gastro.2015.06.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
98 Jinjuvadia R, Liangpunsakul S; Translational Research and Evolving Alcoholic Hepatitis Treatment Consortium. Trends in Alcoholic Hepatitis-related Hospitalizations, Financial Burden, and Mortality in the United States. J Clin Gastroenterol 2015;49:506-11. [PMID: 25198164 DOI: 10.1097/MCG.0000000000000161] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 9.6] [Reference Citation Analysis]
99 Sanyal AJ, Gao B, Szabo G. Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis. Gastroenterology 2015;149:4-9. [PMID: 26008859 DOI: 10.1053/j.gastro.2015.05.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
100 Dugum M, McCullough A. Diagnosis and Management of Alcoholic Liver Disease. J Clin Transl Hepatol 2015;3:109-16. [PMID: 26356792 DOI: 10.14218/JCTH.2015.00008] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
101 Kim W. [Diagnostic and therapeutic strategies for severe alcoholic hepatitis]. Korean J Gastroenterol 2015;65:4-11. [PMID: 25603848 DOI: 10.4166/kjg.2015.65.1.4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
102 Tilg H, Gao B. Dietary saturated lipids in alcoholic liver disease: new microbiota-targeting bullets? Gastroenterology 2015;148:16-9. [PMID: 25451649 DOI: 10.1053/j.gastro.2014.11.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
103 Lazaro R, Wu R, Lee S, Zhu NL, Chen CL, French SW, Xu J, Machida K, Tsukamoto H. Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice. Hepatology 2015;61:129-40. [PMID: 25132354 DOI: 10.1002/hep.27383] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 10.6] [Reference Citation Analysis]
104 González-Reimers E, Santolaria-Fernández F, Martín-González MC, Fernández-Rodríguez CM, Quintero-Platt G. Alcoholism: A systemic proinflammatory condition. World J Gastroenterol 2014; 20(40): 14660-14671 [PMID: 25356029 DOI: 10.3748/wjg.v20.i40.14660] [Cited by in CrossRef: 108] [Cited by in F6Publishing: 112] [Article Influence: 12.0] [Reference Citation Analysis]
105 Testino G, Burra P, Bonino F, Piani F, Sumberaz A, Peressutti R, Castiglione AG, Patussi V, Fanucchi T, Ancarani O, Cerce GD, Iannini AT, Greco G, Mosti A, Durante M, Babocci P, Quartini M, Mioni D, Aricò S, Baselice A, Leone S, Lozer F, Scafato E, Borro P. Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: An Italian position statement. World J Gastroenterol 2014; 20(40): 14642-14651 [PMID: 25356027 DOI: 10.3748/wjg.v20.i40.14642] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
106 Kim W, Kim DJ. Severe alcoholic hepatitis-current concepts, diagnosis and treatment options. World J Hepatol 2014; 6(10): 688-695 [PMID: 25349640 DOI: 10.4254/wjh.v6.i10.688] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
107 Higuera-de la Tijera F, Servín-caamaño AI, Pérez-torres E, Salas-gordillo F, Abdo-francis JM, Pérez-hernández JL, Kershenobich D. Main clinical factors influencing early mortality in a cohort of patients with severe alcoholic hepatitis, and evaluation trough ROC curves of different prognostic scoring systems. Revista Médica Del Hospital General De México 2014;77:160-6. [DOI: 10.1016/j.hgmx.2014.10.003] [Reference Citation Analysis]
108 Williams JA, Manley S, Ding WX. New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases. World J Gastroenterol 2014; 20(36): 12908-12933 [PMID: 25278688 DOI: 10.3748/wjg.v20.i36.12908] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 69] [Article Influence: 7.2] [Reference Citation Analysis]
109 Shoreibah M, Anand BS, Singal AK. Alcoholic hepatitis and concomitant hepatitis C virus infection. World J Gastroenterol 2014; 20(34): 11929-11934 [PMID: 25232227 DOI: 10.3748/wjg.v20.i34.11929] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
110 Chayanupatkul M, Liangpunsakul S. Alcoholic hepatitis: A comprehensive review of pathogenesis and treatment. World J Gastroenterol 2014; 20(20): 6279-6286 [PMID: 24876748 DOI: 10.3748/wjg.v20.i20.6279] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
111 Jaurigue MM, Cappell MS. Therapy for alcoholic liver disease. World J Gastroenterol 2014; 20(9): 2143-2158 [PMID: 24605013 DOI: 10.3748/wjg.v20.i9.2143] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
112 Kasztelan-Szczerbinska B, Slomka M, Celinski K, Szczerbinski M. Alkaline phosphatase: the next independent predictor of the poor 90-day outcome in alcoholic hepatitis. Biomed Res Int. 2013;2013:614081. [PMID: 24151614 DOI: 10.1155/2013/614081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]